ETF Watching: Direxion Daily Healthcare Bear 3X ETF (SICK) Declines 1.57% for Nov 25

November 25, 2016 - By Hazel Jackson   ·   0 Comments

Nov 25 is a negative day so far for Direxion Daily Healthcare Bear 3X ETF (NYSEARCA:SICK) as the ETF is active during the day after losing 1.57% to hit $35.75 per share. The exchange traded fund has 1.69 million net assets and 2.07% volatility this month.

Over the course of the day 600 shares traded hands, as compared to an average volume of 2,260 over the last 30 days for Direxion Daily Healthcare Bear 3X ETF (NYSEARCA:SICK).

The ETF is -38.64% of its 52-Week High and 14.90% of its low, and is currently having ATR of 1.38. This year’s performance is -8.86% while this quarter’s performance is 14.06%.

The ETF’s YTD performance is 97.11%, the 1 year is 97.11% and the 3 year is 25.38%.

The fund’s top holdings are: Fidelity Institutional Go for 51.70% of assets, Health Care Sel Sec Index for 49.58%, Goldman Finl Sq Trsry Ins for 8.50%.

More notable recent Direxion Daily Healthcare Bear 3X Shares (NYSEARCA:SICK) news were published by: Benzinga.com which released: “Don’t Get SICK Of Healthcare ETFs And Stocks; Try This Instead” on November 15, 2016, also Etfdb.com with their article: “SICK vs. CURE: Direxion Rolls Out Leveraged Health Care ETFs” published on June 15, 2011, Etftrends.com published: “Triple-Leveraged Biotech ETFs Could be Coming Soon” on March 20, 2015. More interesting news about Direxion Daily Healthcare Bear 3X Shares (NYSEARCA:SICK) were released by: Benzinga.com and their article: “A New Bearish Biotech ETF And A Lazarus Act For A Couple Leveraged Funds” published on December 03, 2015 as well as Etfdailynews.com‘s news article titled: “Direxion Announces Reverse and Forward Share Splits Of 9 ETFs” with publication date: August 19, 2013.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Hazel Jackson


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>